Dominic J. Wells

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri et al. · The Lancet · 2011 · 852 citations · Full text

Exon Skipping, Urology, Duchenne Muscular Dystrophy +4

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Maria Kinali, Virginia Arechavala‐Gomeza, Lucy Feng et al. · The Lancet Neurology · 2009 · 635 citations · Full text

Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering

Sara M. Maffioletti, Shilpita Sarcar, A. Henderson et al. · Cell Reports · 2018 · 310 citations · Full text

Gene expression in skeletal muscle in response to stretch and force generation

Geoffrey Goldspink, Andrew Scutt, P. T. Loughna et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1992 · 224 citations

Muscle Function, Engineering, Myosin Cross Bridge +17

Musculoskeletal Geometry, Muscle Architecture and Functional Specialisations of the Mouse Hindlimb

James P. Charles, Ornella Cappellari, Andrew J. Spence et al. · PLoS ONE · 2016 · 157 citations · Full text